What led to the muted performance in the generics business? Generics revenue was Rs 624 crore, a decline of 8% YoY, ...

Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

Committee members said there was uncertainty around sotagliflozin in patients with kidney disease. The FDA is currently ...

Shares of pharmaceutical company Biocon tanked 5.96 per cent at Rs 301.65 a piece on the BSE. Biocon share price today fell ...

Biocon's net profit declined to Rs 27.1 crore in the September quarter, as compared to Rs 172.7 crore in the year-ago period.

Explainer-Who in the US Benefits From $35 Insulin? By Ahmed Aboulenein WASHINGTON (Reuters) - Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin ...

WASHINGTON (Reuters) - Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a major accomplishment of the Biden administration ...

This company is a leading developer of needle-free devices to administer therapeutics subcutaneously, which are designed to ...

for the delivery of U-100 insulin to individuals with diabetes and subcutaneous biosimilar products using NuGen's InsuJetTM device and consumables. U-100 insulin is the standard and most used strength ...

for the delivery of U-100 insulin to individuals with diabetes and subcutaneous biosimilar products using NuGen's InsuJetTM device and consumables. U-100 insulin is the standard and most used ...